Direct Activation of Bax by p53 Mediates Mitochondrial Membrane Permeabilization and Apoptosis
The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Abstract
The tumor suppressor p53 exerts its anti-neoplastic activity primarily through the induction of apoptosis. We found that cytosolic localization of endogenous wild-type or trans-activation-deficient p53 was necessary and sufficient for apoptosis. p53 directly activated the proapoptotic Bcl-2 protein Bax in the absence of other proteins to permeabilize mitochondria and engage the apoptotic program. p53 also released both proapoptotic multidomain proteins and BH3-only proteins [Proapoptotic Bcl-2 family proteins that share only the third Bcl-2 homology domain (BH3)] that were sequestered by Bcl-xL. The transcription-independent activation of Bax by p53 occurred with similar kinetics and concentrations to those produced by activated Bid. We propose that when p53 accumulates in the cytosol, it can function analogously to the BH3-only subset of proapoptotic Bcl-2 proteins to activate Bax and trigger apoptosis.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“This includes pro-apoptotic members of the Bcl-2 family (e.g., PUMA, Bax), which mediate mitochondrial outer membrane permeabilization and subsequent caspase activation, to dismantle the cell (Nakano and Vousden, 2001; Chipuk et al., 2004; Aubrey et al., 2018).”
From USP7 Is a Master Regulator of Genome Stability (2020) · cites this paper as Chipuk et al., 2004
In the citing paper
“p53 directly activates the pro-apoptotic protein Bak or disrupts the Mcl-1 and Bak complex, releasing Bak and initiating apoptosis.37,72”
From Targeting p53 pathways: mechanisms, structures, and advances in therapy (2023) · cites this paper as [37]
In the citing paper
“Stabilized p53 forms tetramers in the nucleus, binds to target DNA and regulates gene transcription, leading to alterations in downstream signaling pathways.33–37”
From Targeting p53 pathways: mechanisms, structures, and advances in therapy (2023) · cites this paper as [37]
Citations
Cites
The Release of Cytochrome c from Mitochondria: A Primary Site for Bcl-2 Regulation of Apoptosis
Kluck, R. M., Bossy-Wetzel, E., Green, D. R., & Newmeyer, D. D. (1997) · Science · doi:10.1126/science.275.5303.1132 · Cited by 4,714
Self-citationTumor suppressor p53 is a direct transcriptional activator of the human bax gene
Toshiyuki, M., & Reed, J. C. (1995) · Cell · doi:10.1016/0092-8674(95)90412-3 · Cited by 4,063
Proapoptotic BAX and BAK: A Requisite Gateway to Mitochondrial Dysfunction and Death
Wei, M. C., Zong, W.-X., Cheng, E. H.-Y., Lindsten, T., Panoutsakopoulou, V., Ross, A. J., Roth, K. A., MacGregor, G. R., Thompson, C. B., & Korsmeyer, S. J. (2001) · Science · doi:10.1126/science.1059108 · Cited by 3,988
Noxa, a BH3-Only Member of the Bcl-2 Family and Candidate Mediator of p53-Induced Apoptosis
Oda, E., Ohki, R., Murasawa, H., Nemoto, J., Shibue, T., Yamashita, T., Tokino, T., Taniguchi, T., & Tanaka, †. N. (2000) · Science · doi:10.1126/science.288.5468.1053 · Cited by 2,112
Bad, a heterodimeric partner for Bcl-xL and Bcl-2, displaces bax and promotes cell death
Yang, E., Zha, J., Jockel, J., Boise, L. H., Thompson, C. B., & Korsmeyer, S. J. (1995) · Cell · doi:10.1016/0092-8674(95)90411-5 · Cited by 2,100
p53 Has a Direct Apoptogenic Role at the Mitochondria
Mihara, M., Erster, S., Zaika, A., Petrenko, O., Chittenden, T., Pancoska, P., & Moll, U. M. (2003) · Molecular Cell · doi:10.1016/s1097-2765(03)00050-9 · Cited by 1,777
Cheng, E. H.-Y. A., Wei, M. C., Weiler, S., Flavell, R. A., Mak, T. W., Lindsten, T., & Korsmeyer, S. J. (2001) · Molecular Cell · doi:10.1016/s1097-2765(01)00320-3 · Cited by 1,707
Letai, A., Bassik, M. C., Walensky, L. D., Sorcinelli, M. D., Weiler, S., & Korsmeyer, S. J. (2002) · Cancer Cell · doi:10.1016/s1535-6108(02)00127-7 · Cited by 1,677
Bid, Bax, and Lipids Cooperate to Form Supramolecular Openings in the Outer Mitochondrial Membrane
Kuwana, T., Mackey, M. R., Perkins, G., Ellisman, M. H., Latterich, M., Schneiter, R., Green, D. R., & Newmeyer, D. D. (2002) · Cell · doi:10.1016/s0092-8674(02)01036-x · Cited by 1,478
Self-citationp53- and Drug-Induced Apoptotic Responses Mediated by BH3-Only Proteins Puma and Noxa
Villunger, A., Michalak, E. M., Coultas, L., Müllauer, F., Böck, G., Ausserlechner, M. J., Adams, J. M., & Strasser, A. (2003) · Science · doi:10.1126/science.1090072 · Cited by 1,327
Research works printed but not linked: 1
- C. A. Vater, L. M. Bartle, C. A. Dionne, T. D. Littlewood, V. S. Goldmacher, Oncogene13, 739 (1996).
Cited by
Repertoires of Autophagy in the Pathogenesis of Ocular Diseases
Li, Y.-J., Jiang, Q., Cao, G.-F., Yao, J., & Yan, B. (2015) · Cellular Physiology and Biochemistry · doi:10.1159/000373980 · Cited by 16,304
Galluzzi, L., Vitale, I., Aaronson, S. A., Abrams, J. M., Adam, D., Agostinis, P., Alnemri, E. S., Altucci, L., Amelio, I., Andrews, D. W., et al. (2018) · Cell Death & Differentiation · doi:10.1038/s41418-017-0012-4 · Cited by 6,680
Self-citationMitochondrial Dysfunction and Oxidative Stress in Neurodegenerative Diseases
Lin, M. T., & Beal, M. F. (2006) · Nature · doi:10.1038/nature05292 · Cited by 6,455
Danial, N. N., & Korsmeyer, S. J. (2004) · Cell · doi:10.1016/s0092-8674(04)00046-7 · Cited by 4,651
Mitochondrial membrane permeabilization in cell death
Kroemer, G., Galluzzi, L., & Brenner, C. (2007) · Physiological Reviews · doi:10.1152/physrev.00013.2006 · Cited by 3,598
“p53 might also activate the pore-forming, MMP-inducing function of Bax (131) or Bak (443).”
BackgroundThe Pathophysiology of Mitochondrial Cell Death
Green, D. R., & Kroemer, G. (2004) · Science · doi:10.1126/science.1099320 · Cited by 3,418
Self-citationExtrinsic versus intrinsic apoptosis pathways in anticancer chemotherapy
Fulda, S., & Debatin, K.-M. (2006) · Oncogene · doi:10.1038/sj.onc.1209608 · Cited by 2,312
“…of the outer mitochondrial membrane in a transcriptionindependent fashion through direct activation of proapoptotic Bcl-2 proteins Bax or Bak or through binding and inactivating of antiapoptotic Bcl-2 proteins such as Bcl-2 or Bcl-XL (Mihara et al., 2003; Chipuk et al., 2004; Moll et al., 2005).”
BackgroundThe Bcl-2 apoptotic switch in cancer development and therapy
Adams, J. M., & Cory, S. (2007) · Oncogene · doi:10.1038/sj.onc.1210220 · Cited by 2,176
“Multiple targets of this transcription factor have been implicated, and it has even been proposed that p53 has a direct apoptogenic role at the mitochondrion by engaging either Bcl-xL and Bcl-2 (Mihara et al., 2003) or Bax (Chipuk et al., 2004).”
BackgroundThe first 30 years of p53: growing ever more complex.
Levine, A. J., & Oren, M. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2723 · Cited by 1,967
Cisplatin nephrotoxicity: Mechanisms and renoprotective strategies
Pabla, N., & Dong, Z. (2008) · Kidney International · doi:10.1038/sj.ki.5002786 · Cited by 1,918
“It is noteworthy that, in addition to gene transcription, p53 may also induce apoptosis by directly activating proapoptotic Bcl-2 family proteins, leading to mitochondrial injury and the release of apoptogenic factors.(81) Whether the direct mechanism is involved in cisplatin-induced renal tubular cell death is unknow…”
BackgroundLiquid droplet formation by HP1α suggests a role for phase separation in heterochromatin
Larson, A. G., Elnatan, D., Keenen, M. M., Trnka, M. J., Johnston, J. B., Burlingame, A. L., Agard, D. A., Redding, S., & Narlikar, G. J. (2017) · Nature · doi:10.1038/nature22822 · Cited by 1,694
Targeting mitochondria for cancer therapy
Fulda, S., Galluzzi, L., & Kroemer, G. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd3137 · Cited by 1,629
Kruse, J.-P., & Gu, W. (2009) · Cell · doi:10.1016/j.cell.2009.04.050 · Cited by 1,610
Chipuk, J. E., Moldoveanu, T., Llambi, F., Parsons, M. J., & Green, D. R. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.01.025 · Cited by 1,427
“Cytosolic p53 is also suggested to function as a derepressor BH3-only protein; and multiple domains within p53 are implicated in these activities (Chipuk et al., 2004; Pietsch et al., 2008).”
BackgroundSelf-citationLysosomal membrane permeabilization in cell death
Boya, P., & Kroemer, G. (2008) · Oncogene · doi:10.1038/onc.2008.310 · Cited by 1,426
“However, p53 can also translocate to mitochondria and induce permeabilization of the outer mitochondrial membrane by forming complexes with the multidomain proteins from the Bcl-2 family, resulting in cytochrome c release (Mihara et al., 2003; Chipuk et al., 2004).”
BackgroundMitochondria in Apoptosis: Bcl-2 Family Members and Mitochondrial Dynamics
Martinou, J.-C., & Youle, R. J. (2011) · Developmental Cell · doi:10.1016/j.devcel.2011.06.017 · Cited by 1,368
“Other triggers, including BH3-only proteins, prostaglandins (Lalier et al., 2011), p53 (Chipuk et al., 2004), pH variations (Khaled et al., 1999), or posttranslational modifications (Kutuk and Letai, 2008), all could also be responsible for sending Bax to the OMM.”
BackgroundCalpain-mediated cleavage of Atg5 switches autophagy to apoptosis
Yousefi, S., Perozzo, R., Schmid, I., Ziemiecki, A., Schaffner, T., Scapozza, L., Brunner, T., & Simon, H.-U. (2006) · Nature Cell Biology · doi:10.1038/ncb1482 · Cited by 1,158
Regulating the p53 pathway: in vitro hypotheses, in vivo veritas
Toledo, F., & Wahl, G. M. (2006) · Nature reviews. Cancer · doi:10.1038/nrc2012 · Cited by 1,286
Mitochondrial Oxidative Stress: Implications for Cell Death
Orrenius, S., Gogvadze, V., & Zhivotovsky, B. (2007) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.47.120505.105122 · Cited by 1,272
Kuwana, T., Bouchier-Hayes, L., Chipuk, J. E., Bonzon, C., Sullivan, B. A., Green, D. R., & Newmeyer, D. D. (2005) · Molecular Cell · doi:10.1016/j.molcel.2005.02.003 · Cited by 1,185
“For example, family proteins, although regulatory partners outside the family may also be important (Chipuk et al., 2004; Cud-E -Myc tumor cells can undergo apoptosis when Bcl-2 is downregulated (Letai et al., 2004). deback et al., 2001; Guo et al., 2003; Sawada et al., 2003).”
BackgroundSelf-citationRegulation of autophagy by cytoplasmic p53
Tasdemir, E., Maiuri, M. C., Galluzzi, L., Vitale, I., Djavaheri-Mergny, M., D'Amelio, M., Criollo, A., Morselli, E., Zhu, C., Harper, F., et al. (2008) · Nature Cell Biology · doi:10.1038/ncb1730 · Cited by 1,132
Modulation of microRNA processing by p53
Suzuki, H. I., Yamagata, K., Sugimoto, K., Iwamoto, T., Kato, S., & Miyazono, K. (2009) · Nature · doi:10.1038/nature08199 · Cited by 1,124
Apoptosis and Molecular Targeting Therapy in Cancer
Hassan, M., Watari, H., AbuAlmaaty, A., Ohba, Y., & Sakuragi, N. (2014) · BioMed Research International · doi:10.1155/2014/150845 · Cited by 1,121
“As recently summarized, antiapoptotic proteins prevent Bax/Bak activation by sequestering/inhibiting “activator” BH3-only proteins and/or directly inhibiting Bax/Bak activation [33].”
BackgroundInfluentialRetractedFricker, M., Tolkovsky, A. M., Borutaite, V., Coleman, M., & Brown, G. C. (2018) · Physiological Reviews · doi:10.1152/physrev.00011.2017 · Cited by 1,108
“Although this study highlights the relative importance of this subset of BH3-only proteins in causing apoptosis in a variety of cell types, the lack of complete phenocopy of the Bax/Bak double knockout argues against the absolute requirement for direct activation for Bax activation or indicate that other direct activa…”
Cytoplasmic functions of the tumour suppressor p53
Green, D. R., & Kroemer, G. (2009) · Nature · doi:10.1038/nature07986 · Cited by 1,106
Self-citationBcl-2 Inhibitors: Targeting Mitochondrial Apoptotic Pathways in Cancer Therapy
Kang, M. H., & Reynolds, C. P. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-0144 · Cited by 1,016
Targeting p53 pathways: mechanisms, structures, and advances in therapy
Wang, H., Guo, M., Wei, H., & Chen, Y. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01347-1 · Cited by 1,016
“p53 directly activates the pro-apoptotic protein Bak or disrupts the Mcl-1 and Bak complex, releasing Bak and initiating apoptosis.(37,72) In addition, p53-driven miR34a expression may sensitize cells to apoptotic stimuli by decreasing Bcl-2 levels.”
BackgroundHow do BCL-2 proteins induce mitochondrial outer membrane permeabilization?
Chipuk, J. E., & Green, D. R. (2008) · Trends in Cell Biology · doi:10.1016/j.tcb.2008.01.007 · Cited by 985
“For example, cytosolic p53 was shown to activate BAX in an LUV system, and the participation of cytosolic p53 in a de-repressor/direct activator pathway has been demonstrated [27, 36 ].”
Self-citationControl of mitochondrial apoptosis by the Bcl-2 family
Brunelle, J. K., & Letai, A. (2009) · Journal of Cell Science · doi:10.1242/jcs.031682 · Cited by 929
“In fact, there are data that support the role of Puma, p53 and heat as activators of Bax and Bak (Chipuk et al., 2004; Kim et al., 2006; Pagliari et al., 2005), and possibly others remain undiscovered.”
BackgroundRole of Bcl-2 family proteins and caspases in the regulation of apoptosis
Ola, M. S., Nawaz, M., & Ahsan, H. (2011) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-010-0709-x · Cited by 920
“However, it is likely that additional factors other than Bid and Bim can act as activators such as Puma, p53, and heat as activators of Bax and Bak [58–60], and possibly others.”
Backgroundp53 ubiquitination: Mdm2 and beyond
Brooks, C. L., & Gu, W. (2006) · Molecular Cell · doi:10.1016/j.molcel.2006.01.020 · Cited by 924
“Moreover, movement of p53 into the cytoplasm may be important for transcription-independent functions of p53 such as interactions with mitochondrial proteins in the apoptosis response (Chipuk et al., 2004; Leu et al., 2004; Mihara et al., 2003).”
BackgroundBcl-2 family proteins and cancer
Yip, K. W., & Reed, J. C. (2008) · Oncogene · doi:10.1038/onc.2008.307 · Cited by 881
“…with pro- and antiapoptotic Bcl-2-family proteins have been observed, directly modulating the bioactivities of the p21-Bax and p26-Bcl-2 proteins, and suggesting that p53 regulates the Bcl-2 family at both transcriptional and post-transcriptional levels (Chipuk et al., 2004; Deng et al., 2006).”
BackgroundMitochondria and Mitophagy: The Yin and Yang of Cell Death Control
Kubli, D. A., & Gustafsson, Å. B. (2012) · Circulation Research · doi:10.1161/circresaha.112.265819 · Cited by 796
Systems biology of cisplatin resistance: past, present and future
Galluzzi, L., Vitale, I., Michels, J., Brenner, C., Szabadkai, G., Harel-Bellan, A., Castedo, M., & Kroemer, G. (2014) · Cell Death & Disease · doi:10.1038/cddis.2013.428 · Cited by 782
Mitochondrial p53 activates Bak and causes disruption of a Bak–Mcl1 complex
Leu, J. I.-J., Dumont, P., Hafey, M., Murphy, M. E., & George, D. L. (2004) · Nature Cell Biology · doi:10.1038/ncb1123 · Cited by 770
Tumor suppressor p53: Biology, signaling pathways, and therapeutic targeting
Hernández Borrero, L. J., & El-Deiry, W. S. (2021) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2021.188556 · Cited by 748
Life in the balance: how BH3-only proteins induce apoptosis
Willis, S. N., & Adams, J. M. (2005) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2005.10.001 · Cited by 743
“A conundrum regarding the apoptotic activity of p53 is that its transcriptional target Puma is required for almost all the apoptotic response of lymphocytes to DNA damage [20 ,21 ], yet some studies have argued that p53 can also directly activate apoptosis from the cytoplasm by engaging either Bcl-2 and Bcl-xL [75] or…”
BackgroundTip60-Dependent Acetylation of p53 Modulates the Decision between Cell-Cycle Arrest and Apoptosis
Tang, Y., Luo, J., Zhang, W., & Gu, W. (2006) · Molecular Cell · doi:10.1016/j.molcel.2006.11.021 · Cited by 727
“In addition, p53 also transactivatesthemdm2genetoinitiatethep53-Mdm2feedback loop, which is crucial for restraining p53 function during the stress response (Michael and Oren, 2002; Brooks and Gu, 2006 ).”
BackgroundInfluentialDrugging the p53 pathway: understanding the route to clinical efficacy
Khoo, K. H., Verma, C. S., & Lane, D. P. (2014) · Nature Reviews Drug Discovery · doi:10.1038/nrd4236 · Cited by 719
Samudio, I., Harmancey, R., Fiegl, M., Kantarjian, H., Konopleva, M., Korchin, B., Kaluarachchi, K., Bornmann, W., Duvvuri, S., Taegtmeyer, H., et al. (2010) · Journal of Clinical Investigation · doi:10.1172/jci38942 · Cited by 709
BCL-2 family isoforms in apoptosis and cancer
Warren, C. F. A., Wong-Brown, M. W., & Bowden, N. A. (2019) · Cell Death & Disease · doi:10.1038/s41419-019-1407-6 · Cited by 700
The tumor suppressor protein p53 and the ferroptosis network
Kang, R., Kroemer, G., & Tang, D. (2019) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2018.05.074 · Cited by 698
“For example, cytosolic p53 can directly bind to pro-apoptotic members of the BCL-2 family (BAX [BCL2 associated X, apoptosis regulator] and BBC3/PUMA [BCL2 binding component 3]) to increase mitochondrial membrane permeabilization and the release of pro-apoptotic factors from the mitochondria [4,5].”
BAX activation is initiated at a novel interaction site
Gavathiotis, E., Suzuki, M., Davis, M. L., Pitter, K., Bird, G. H., Katz, S. G., Tu, H.-C., Kim, H., Cheng, E. H.-Y., Tjandra, N., et al. (2008) · Nature · doi:10.1038/nature07396 · Cited by 700
The mystery of BCL2 family: Bcl-2 proteins and apoptosis: an update
Siddiqui, W. A., Ahad, A., & Ahsan, H. (2015) · Archives of Toxicology · doi:10.1007/s00204-014-1448-7 · Cited by 696
Apoptosis: a basic biological phenomenon with wide‐ranging implications in human disease
FADEEL, B., & ORRENIUS, S. (2005) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2005.01570.x · Cited by 698
Martin, L. J., Pan, Y., Price, A. C., Sterling, W., Copeland, N. G., Jenkins, N. A., Price, D. L., & Lee, M. K. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.4308-05.2006 · Cited by 684
“p53 can mediate mitochondrial membrane permeabilization and apoptosis by activating Bax and Bak (Chipuk et al., 2004; Leu et al., 2004).”
BackgroundMultiple Functions of BCL-2 Family Proteins
Hardwick, J. M., & Soane, L. (2013) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a008722 · Cited by 564
“2009), and others (Chipuk et al. 2004).”
p53 polymorphisms: cancer implications
Whibley, C., Pharoah, P. D. P., & Hollstein, M. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2584 · Cited by 665
The P53 pathway: what questions remain to be explored?
Levine, A. J., Hu, W., & Feng, Z. (2006) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4401910 · Cited by 659
Regulation of Reactive Oxygen Species Generation in Cell Signaling
Bae, Y. S., Oh, H., Rhee, S. G., & Yoo, Y. D. (2011) · Molecules and Cells · doi:10.1007/s10059-011-0276-3 · Cited by 658
“However, many studies have reported that a fraction of cellular p53 migrates into the outer mitochondrial membrane in response to a variety of stress signals, including DNA damage and hypoxic stress, and promotes transcription-independent p53-mediated cell death (Chipuk et al., 2004; Dumont et al., 2003; Mihara et al.…”
BackgroundInfluentialMitochondria in cancer cells: what is so special about them?
Gogvadze, V., Orrenius, S., & Zhivotovsky, B. (2008) · Trends in Cell Biology · doi:10.1016/j.tcb.2008.01.006 · Cited by 637
“Interestingly, p53 can also regulate OMM permeabilization through direct activation of Bax [ 68 ].”
`The stress of dying': the role of heat shock proteins in the regulation of apoptosis
Beere, H. M. (2004) · Journal of Cell Science · doi:10.1242/jcs.01284 · Cited by 639
“JNK phosphorylates c-Myc and p53 (Fuchs et al., 1998a; Fuchs et al., 1998b; Noguchi et al., 1999), both of which have been implicated in the release of cytochrome c (Chipuk et al., 2003; Chipuk et al., 2004; Juin et al., 1999; Schuler et al., 2000).”
BackgroundThe mitochondrial pathways of apoptosis
Estaquier, J., Vallette, F., Vayssiere, J.-L., & Mignotte, B. (2012) · Advances in experimental medicine and biology · doi:10.1007/978-94-007-2869-1_7 · Cited by 637
“Parl is localized in the inner mitochondrial membrane, with the N-terminus exposed to the matrix and the C-terminus to the IMS (Jeyaraju et al., 2006).”
InfluentialMitochondrial outer membrane permeabilization during apoptosis: the innocent bystander scenario
Chipuk, J. E., Bouchier-Hayes, L., & Green, D. R. (2006) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4401963 · Cited by 631
Self-citationMechanisms of Early Brain Injury after Subarachnoid Hemorrhage
Cahill, W. J., Calvert, J. H., & Zhang, J. H. (2006) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/sj.jcbfm.9600283 · Cited by 630
“It has been suggested that the accumulation of p53 in the nucleus leads to the translocation of p53 into the cytoplasm (Sansome et al, 2001; Chipuk et al, 2004; Erster et al, 2004), where it acts either directly or indirectly on the mitochondria resulting in cytochrome c release.”
BackgroundVaseva, A. V., & Moll, U. M. (2009) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2008.10.005 · Cited by 618
“Indeed, purified p53 is able to displace tBid and Bax from inhibitory complexes formed with Bcl-xL in vitro [13].”
InfluentialMolecular Mechanisms of Apoptosis and Roles in Cancer Development and Treatment
Goldar, S., Khaniani, M. S., Derakhshan, S. M., & Baradaran, B. (2015) · Asian Pacific Journal of Cancer Prevention · doi:10.7314/apjcp.2015.16.6.2129 · Cited by 606
“MOMP is most commonly mediated via a variety of proteinmembrane and protein-protein interactions of the B-cell lymphoma 2 protein (BCL-2) family (Chipuk et al., 2004).”
The Mitochondrial Death Pathway and Cardiac Myocyte Apoptosis
Crow, M. T., Mani, K., Nam, Y.-J., & Kitsis, R. N. (2004) · Circulation Research · doi:10.1161/01.res.0000148632.35500.d9 · Cited by 590
Major apoptotic mechanisms and genes involved in apoptosis
Kiraz, Y., Adan, A., Kartal Yandim, M., & Baran, Y. (2016) · Tumor Biology · doi:10.1007/s13277-016-5035-9 · Cited by 582
“Moreover, cytosolic p53 might induce the activation of pro-apoptotic Bax via direct protein-protein interactions [150].”
BackgroundDiagnosing and exploiting cancer's addiction to blocks in apoptosis
Letai, A. G. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2297 · Cited by 580
Linkermann, A., Chen, G., Dong, G., Kunzendorf, U., Krautwald, S., & Dong, Z. (2014) · Journal of the American Society of Nephrology · doi:10.1681/asn.2014030262 · Cited by 563
PUMA Couples the Nuclear and Cytoplasmic Proapoptotic Function of p53
Chipuk, J. E., Bouchier-Hayes, L., Kuwana, T., Newmeyer, D. D., & Green, D. R. (2005) · Science · doi:10.1126/science.1114297 · Cited by 546
Self-citationMitochondrial dysfunction and oxidative stress in aging and cancer
Kudryavtseva, A. V., Krasnov, G. S., Dmitriev, A. A., Alekseev, B. Y., Kardymon, O. L., Sadritdinova, A. F., Fedorova, M. S., Pokrovsky, A. V., Melnikova, N. V., Kaprin, A. D., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.9821 · Cited by 543
“com/oncotarget conformational changes [95-98].”
Hoshino, A., Mita, Y., Okawa, Y., Ariyoshi, M., Iwai-Kanai, E., Ueyama, T., Ikeda, K., Ogata, T., & Matoba, S. (2013) · Nature Communications · doi:10.1038/ncomms3308 · Cited by 536
Coping with stress: multiple ways to activate p53
Horn, H. F., & Vousden, K. H. (2007) · Oncogene · doi:10.1038/sj.onc.1210263 · Cited by 522
“Recent studies have demonstrated an unexpected transcriptionally independent function for this pool of p53 as a BH3only protein, inducing apoptosis by directly binding to the pro-apoptotic proteins Bax and Bak, as well as the anti-apoptotic proteins like BclxL (Mihara et al., 2003; Chipuk et al., 2004; Leu et al., 200…”
BackgroundRecent advances in apoptosis, mitochondria and drug resistance in cancer cells
Indran, I. R., Tufo, G., Pervaiz, S., & Brenner, C. (2011) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2011.03.010 · Cited by 526
Autophagy delays apoptotic death in breast cancer cells following DNA damage
Abedin, M. J., Wang, D., McDonnell, M. A., Lehmann, U., & Kelekar, A. (2007) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4402039 · Cited by 523
“A proapoptotic function for mitochondrially localized p53, independent of its transcriptional activator function, has been described.(14,15) At the mitochondria, p53 can interact with Bcl-xL as well as Bax; the disruption of a p53/Bcl-xL interaction by BH3-only protein, Puma, allows p53 to interact with Bax and promot…”
BackgroundDeng, J., Carlson, N., Takeyama, K., Dal Cin, P., Shipp, M., & Letai, A. (2007) · Cancer Cell · doi:10.1016/j.ccr.2007.07.001 · Cited by 513
“Indeed, evidence already exists that activation of BAX and BAK can occur via PUMA or p53, and there is no reason to believe that all activators have been discovered (Chipuk et al., 2004; Kim et al., 2006).”
BackgroundRasola, A., & Bernardi, P. (2007) · Apoptosis · doi:10.1007/s10495-007-0723-y · Cited by 508
“Interestingly, cytosolic p53 can directly activate Bax and thereby cause permeabilization of the OMM, although the mechanism of this activation is still unclear [196].”
Maiuri, M. C., Galluzzi, L., Morselli, E., Kepp, O., Malik, S. A., & Kroemer, G. (2010) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2009.12.001 · Cited by 502
“For instance, cytoplasmic p53 can relocalize to mitochondria and trigger mitochondrial membrane permeabilization [9,10 ], most likely by binding and activating the proapoptotic Bcl-2 family member Bax [11,12] and/or by inhibiting its antiapoptotic counterparts Bcl-2/Bcl-XL [12,13].”
Backgroundp53 Mediates Cellular Dysfunction and Behavioral Abnormalities in Huntington’s Disease
Bae, B.-I., Xu, H., Igarashi, S., Fujimuro, M., Agrawal, N., Taya, Y., Hayward, S. D., Moran, T. H., Montell, C., Ross, C. A., et al. (2005) · Neuron · doi:10.1016/j.neuron.2005.06.005 · Cited by 485
“The increased p53 occurs selectively in the P1 fractions designated as crude nuclei (Figure 1A) in 1% SDS-soluble, nonaggregate fractions (Figure 1C), implying that the transactivation-independent role for p53 in the mitochondria is unlikely (Chipuk et al., 2004).”
BackgroundArtemisinins: Pharmacological actions beyond anti-malarial
Ho, W. E., Peh, H. Y., Chan, T. K., & Wong, W. S. F. (2014) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2013.12.001 · Cited by 481
“suppressor protein p53, which in turn increases the level of BAX, elevates the BAX/Bcl-2 ratio, and enhances permeabilization of the mitochondria membrane, leading to the release of cytochrome c (caspase activator) and eventually apoptosis (Chipuk et al., 2004).”
BackgroundMitochondrial regulation of apoptotic cell death
Orrenius, S. (2004) · Toxicology Letters · doi:10.1016/j.toxlet.2003.12.017 · Cited by 481
BCL2 family in DNA damage and cell cycle control
Zinkel, S., Gross, A., & Yang, E. (2006) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4401987 · Cited by 474
“can directly interact with BCL2 family members, leading to cytochrome c release.(75) A more recent study showed that, after genotoxic stress, the antiapoptotic BCL-xL protein sequesters cytoplasmic p53, whereas nuclear p53 induces Figure 2 Model for the dual function.”
BackgroundReed, J. C. (2006) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4401975 · Cited by 473
Transcription-independent pro-apoptotic functions of p53
Moll, U. M., Wolff, S., Speidel, D., & Deppert, W. (2005) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2005.09.007 · Cited by 468
“Elegant studies showed that cytosolic p53 can directly activate Bax and thereby induce apoptosis [21 ,31], although the exact mechanism by which p53 activates Bax is still an open question.”
BackgroundMultiple pathways of cytochrome c release from mitochondria in apoptosis
Gogvadze, V., Orrenius, S., & Zhivotovsky, B. (2006) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2006.03.016 · Cited by 466
Swayze, E. E., Siwkowski, A. M., Wancewicz, E. V., Migawa, M. T., Wyrzykiewicz, T. K., Hung, G., Monia, B. P., & Bennett, A. C. F. (2007) · Nucleic Acids Research · doi:10.1093/nar/gkl1071 · Cited by 469
“The upregulation of the pro-apoptotic protein Bax suggests involvement of the p53-mediated apoptosis pathway, as Bax is a key response gene to p53 activation (42,43).”
BackgroundRegulation of apoptosis-associated lysosomal membrane permeabilization
Johansson, A.-C., Appelqvist, H., Nilsson, C., Kågedal, K., Roberg, K., & Öllinger, K. (2010) · Apoptosis · doi:10.1007/s10495-009-0452-5 · Cited by 463
“It is worth noting that p53, under certain circumstances, localizes to the mitochondrial membrane during apoptosis and can trigger mitochondrial membrane permeabilization by direct interaction with Bcl-2 family members [60, 61].”
BackgroundBH3-only proteins in apoptosis and beyond: an overview
Lomonosova, E., & Chinnadurai, G. (2008) · Oncogene · doi:10.1038/onc.2009.39 · Cited by 458
“A transcriptionindependent pathway of p53-dependent apoptosis was shown to include physical interaction between mitochondrial p53 and anti- (BCL-2, BCL-xL) and proapoptotic (BAX, BAK) members of the BCL-2 family proteins (Mihara et al., 2003; Chipuk et al., 2004; Leu et al., 2004).”
BackgroundDissecting p53-dependent apoptosis
Chipuk, J. E., & Green, D. R. (2006) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4401908 · Cited by 453
“tioned similar to tBid to induce the oligomization and pore-forming activity of purified, recombinant Bax.(37,47) It is worthy to note that the binding of p53 to Bcl-xL (which would”
InfluentialSelf-citationCurrent Status of Gendicine in China: Recombinant Human Ad-p53 Agent for Treatment of Cancers
Peng, Z. (2005) · Human Gene Therapy · doi:10.1089/hum.2005.16.1016 · Cited by 436
Medicinal mushroom modulators of molecular targets as cancer therapeutics
Zaidman, B.-Z., Yassin, M., Mahajna, J., & Wasser, S. P. (2005) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-004-1787-z · Cited by 434
“2002), and target genes involved in apoptosis-like BAX (Chipuk et al. 2004) and Apaf-1 (Hickman and Helin 2002).”
BackgroundWestphal, D., Kluck, R. M., & Dewson, G. (2014) · Cell Death & Differentiation · doi:10.1038/cdd.2013.139 · Cited by 431
Viral Control of Mitochondrial Apoptosis
Galluzzi, L., Brenner, C., Morselli, E., Touat, Z., & Kroemer, G. (2008) · PLoS Pathogens · doi:10.1371/journal.ppat.1000018 · Cited by 427
“Impaired MMP is associated with multiple pathological conditions, including autoimmune diseases and cancer [S19]. Conversely, unscheduled MMP contributes to the development of diseases characterized by an excess of cell death, such as ischemia/reperfusion injuries, trauma, toxic/metabolic syndromes as well as chronic…”
BackgroundA complex barcode underlies the heterogeneous response of p53 to stress
Murray-Zmijewski, F., Slee, E. A., & Lu, X. (2008) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2451 · Cited by 420
Many players in BCL-2 family affairs
Moldoveanu, T., Follis, A. V., Kriwacki, R. W., & Green, D. R. (2014) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2013.12.006 · Cited by 421
“BAX activation by p53 was abrogated upon ablation of the proline rich region between the transcriptional activation and DNA binding domains of p53 [45].”
BackgroundSelf-citationThe transcriptional targets of p53 in apoptosis control
Yu, J., & Zhang, L. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.03.189 · Cited by 420
Beere, H. M. (2005) · Journal of Clinical Investigation · doi:10.1172/jci26471 · Cited by 414
MDM2 antagonists induce p53-dependent apoptosis in AML: implications for leukemia therapy
Kojima, K., Konopleva, M., Samudio, I. J., Shikami, M., Cabreira-Hansen, M., McQueen, T., Ruvolo, V., Tsao, T., Zeng, Z., Vassilev, L. T., et al. (2005) · Blood · doi:10.1182/blood-2005-02-0553 · Cited by 407
Reactive Oxygen Species in Normal and Tumor Stem Cells
(2014) · Advances in Cancer Research · doi:10.1016/b978-0-12-420117-0.00001-3 · Cited by 403
“[PubMed: 14963330] Chipuk JE, Maurer U, Green DR, Schuler M. Pharmacologic activation of p53 elicits Bax-dependent apoptosis in the absence of transcription.”
BackgroundInfluentialProgrammed cell death via mitochondria: Different modes of dying
Bras, M., Queenan, B., & Susin, S. A. (2005) · Biochemistry (Moscow) · doi:10.1007/s10541-005-0105-4 · Cited by 403
Vidya Priyadarsini, R., Senthil Murugan, R., Maitreyi, S., Ramalingam, K., Karunagaran, D., & Nagini, S. (2010) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2010.09.020 · Cited by 399
Culmsee, C., & Mattson, M. P. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.03.149 · Cited by 389
A Stapled BID BH3 Helix Directly Binds and Activates BAX
Walensky, L. D., Pitter, K., Morash, J., Oh, K. J., Barbuto, S., Fisher, J., Smith, E., Verdine, G. L., & Korsmeyer, S. J. (2006) · Molecular Cell · doi:10.1016/j.molcel.2006.08.020 · Cited by 383
“However, other intact modes of BAX/BAK activation, including the recently identified p53-based BAX activation pathway ( Chipuk et al., 2004, 2005 ), heat-induced activation (Pagliari et al., 2005), and derepression of direct antiapoptotic inhibition of BAX/BAK by other BH3-only proteins (Chen et al., 2005; Kuwana et a…”
BackgroundMechanisms of drug resistance in colon cancer and its therapeutic strategies
Hu, T., Li, Z., Gao, C.-Y., & Cho, C. H. (2016) · World Journal of Gastroenterology · doi:10.3748/wjg.v22.i30.6876 · Cited by 381
Niizuma, K., Endo, H., & Chan, P. H. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.05897.x · Cited by 379
Embedded together: The life and death consequences of interaction of the Bcl-2 family with membranes
Leber, B., Lin, J., & Andrews, D. W. (2007) · Apoptosis · doi:10.1007/s10495-007-0746-4 · Cited by 378
“[62] demonstrated that isolated cellular p53 or recombinant p53”
BackgroundInfluentialAnti- and pro-tumor functions of autophagy
Morselli, E., Galluzzi, L., Kepp, O., Vicencio, J.-M., Criollo, A., Maiuri, M. C., & Kroemer, G. (2009) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2009.01.006 · Cited by 375
“First, it has been demonstrated that active p53 can accumulate in the cytosol and initiate mitochondrial cell death [77–80], either by directly activating Bax [81] and/or by inhibiting anti-apoptotic members of the Bcl-2 protein family [82].”
BackgroundLate viral RNA export, rather than p53 inactivation, determines ONYX-015 tumor selectivity
O'Shea, C. C., Johnson, L., Bagus, B., Choi, S., Nicholas, C., Shen, A., Boyle, L., Pandey, K., Soria, C., Kunich, J., et al. (2004) · Cancer Cell · doi:10.1016/j.ccr.2004.11.012 · Cited by 372
Metadata
- Authors
- Chipuk, J. E., Kuwana, T., Bouchier-Hayes, L., Droin, N. M., Newmeyer, D. D., Schuler, M., & Green, D. R.
- Affiliations
- La Jolla Institute for Immunology (US)
- Division of Cellular Immunology, La Jolla Institute for Allergy and Immunology, 10355 Science Center Drive, San Diego, CA 92121, USA.
- Corresponding author
- Green, Douglas R.
- Venue
- Science
- Published
- 2004-02-13
- Volume
- 303
- Issue
- 5660
- Pages
- 1010-1014
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W1616121322
- Semantic Scholar
- 8ac054acf921abc9f97df5fd7ea018d60ed0c524
- Cited by
- 2,108
- References
- 29
- Citations by year
- 2026: 38 · 2025: 59 · 2024: 60 · 2023: 68 · 2022: 78 · 2021: 88 · 2020: 81 · 2019: 84 · 2018: 88 · 2017: 93 · 2016: 100 · 2015: 91 · 2014: 103 · 2013: 113 · 2012: 103
- FWCI
- 40.11
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute of General Medical Sciences (GM-52735)
- National Institute of Allergy and Infectious Diseases (R01AI040646, R01AI047891)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cell death mechanisms and regulation
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Autophagy in Disease and Therapy
- Keywords
- p53, Bax, apoptosis, mitochondrial membrane permeabilization, Bcl-2 family proteins, BH3-only proteins, Bcl-xL, Bid, tumor suppressor
- MeSH terms
- Animals, Carrier Proteins, Cell Line, Transformed, Cell Nucleus, Cells, Cultured, Cytosol, Gene Expression Regulation, HeLa Cells, Humans, Intracellular Membranes, Liposomes, Mitochondria, Mutation, Permeability, Protein Conformation, Proto-Oncogene Proteins, Recombinant Fusion Proteins, Ultraviolet Rays, Wheat Germ Agglutinins, Genes, p53, Tumor Suppressor Protein p53, Apoptosis, Proto-Oncogene Proteins c-bcl-2, Cytochromes c, bcl-X Protein, BH3 Interacting Domain Death Agonist Protein, bcl-2-Associated X Protein, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.